Supplementary Figure 8 from An Antibody That Locks HER3 in the Inactive Conformation Inhibits Tumor Growth Driven by HER2 or Neuregulin
crossref(2023)
Abstract
PDF file - 181K, Figure S8. PIK3CA mutation is associated with reduced activity contributed by Trastuzumab (T) in Trastuzumab + LJM716 (L) combinations.
Translated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined